Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt repayments
Growth Metrics
Income Statement
Others
Ratios

Cannabist Co Holdings (CBSTF) Capital Expenditures (2021 - 2025)

Cannabist Co Holdings (CBSTF) has disclosed Capital Expenditures for 5 consecutive years, with $248000.0 as the latest value for Q3 2025.

  • Quarterly Capital Expenditures fell 83.66% to $248000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $1.2 million through Sep 2025, up 1428.74% year-over-year, with the annual reading at $1.2 million for FY2024, 70.22% down from the prior year.
  • Capital Expenditures hit $248000.0 in Q3 2025 for Cannabist Co Holdings, down from $1.8 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $40.1 million in Q3 2021 to a low of -$66.4 million in Q4 2022.
  • Historically, Capital Expenditures has averaged $1.5 million across 5 years, with a median of $1.8 million in 2025.
  • Biggest five-year swings in Capital Expenditures: crashed 99.95% in 2023 and later skyrocketed 10300.0% in 2024.
  • Year by year, Capital Expenditures stood at -$56.5 million in 2021, then fell by 17.44% to -$66.4 million in 2022, then soared by 93.62% to -$4.2 million in 2023, then skyrocketed by 30.37% to -$2.9 million in 2024, then skyrocketed by 108.41% to $248000.0 in 2025.
  • Business Quant data shows Capital Expenditures for CBSTF at $248000.0 in Q3 2025, $1.8 million in Q2 2025, and $2.0 million in Q1 2025.